UNDERWEIGHT SPCX with 15-20% trim magnitude, 80-85% benchmark weight residual, $133.20 hard stop, $141.43 re-engagement trigger on volume confirmation
UNDERWEIGHT SPCX with 15-20% trim magnitude, 80-85% benchmark weight residual, $133.20 hard stop, $141.43 re-engagement trigger on volume confirmation. The recommendation explicitly honors the binding 9/01 reflection which identified a smaller tactical trim as the validated template for materially identical setups (coiled chart, MACD contraction, unreclaimed 200 SMA), distinguishing from pure Hold (alpha-destructive) and aggressive 30-50% trim (8/25/8/26 failure pattern). The 8/14 reflection remains dispositive against full Sell given audited operational inflection and institutional floor. Price target of $135 represents ~5% downside from current with 30-45 day horizon.
| Position | Action |
|---|---|
| Default residual after trim | 80-85% of benchmark weight |
| First tranche execution at current levels | Sell 8-10% of position at $140.50-141.00 |
| Second tranche execution on relief bounce | Sell 7-10% on bounce toward $141-143 (50/200 SMA cluster) |
| Residual hard stop | $133.20 closing basis (1× ATR below 50 SMA at $136.18) |
| Do not initiate new long positions | Current levels are not appropriate for new entries |
| Re-engagement on confirmed breakout | Scale to 95-100% benchmark on (a) close >$141.43 on volume ≥80M AND MACD histogram expanding AND Dec cut probability >15% |
| Retest of $141.43 as support | Scale to 110% benchmark on retest of $141.43 holding as support |
| First tactical trim target on long residual | Trim at $146 (recent swing high zone) |
| Second tactical trim target on long residual | Trim at $151.94 (Bollinger upper band) |
| Trail stops once $146 prints | Trail stops to 10 EMA ($137.17) |
SPCX is dramatically undervalued at $140.71 with Morgan Stanley's $300 price target representing 2x upside, supported by accelerating revenue growth, margin expansion, bullish technicals at the 200 SMA pivot, and early-stage institutional accumulation in a secular AI capex cycle.
| Indicator | Value | Signal |
|---|---|---|
| close_10_ema | 140.09 | bullish |
| close_50_sma | 136.18 | bullish |
| close_200_sma | 141.43 | neutral |
| macd | 2.68 | bullish |
| macds | 2.14 | bullish |
| macdh | 0.54 | bullish |
| rsi | 53.52 | neutral |
| boll_lb | 124.99 | neutral |
| boll | 138.46 | neutral |
| boll_ub | 151.94 | neutral |
| atr | 7.47 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Daily close above $141.43 (200 SMA) on volume ≥80M shares AND MACD histogram expanding (≥ +0.65) on breakout bar AND constructive Fed positioning (Dec cut probability >15%)
Then: Upgrade to Overweight, scale to 95-100% benchmark
Morgan Stanley's $300 price target at 2x current price proves the stock is dramatically undervalued, not expensive
↩ rebuts: “Premium valuation is justified by 30%+ growth, expanding margins, and dominant positioning in three secular themes”
EV: +113% (to $300) · concedes: FCF burn of -$14B is real but described as deliberate capex peak; Forward P/E of 87.7x is high but justified by growth trajectory; Post-IPO volatility and choppy price action acknowledged but attributed to pullback creating initiation opportunity
SPCX is a high-risk speculative vehicle priced for perfection at 87.7x forward P/E, with negative TTM earnings, massive FCF burn (-$14.12B), and structural shareholder dilution that makes the bull case contingent on every operational domino falling perfectly.
EV: 125 (Bollinger lower band, ~11% downside from current levels) · concedes: MACD did flip bullish; Gross margin expansion from 41.2% to 49.4% is real; Cash position of $24.75B provides some buffer; Asymmetry not favorable enough to short aggressively at current levels
→ vs conservative: Reading income statement upside down; applying mature-industrial valuation to hyper-growth compounder; 87.7x P/E reflects reinvestment not deterioration; tangible book irrelevant for 47.6% PP&E industrial balance sheet
→ vs neutral: MACD histogram contraction is one-day consolidation in active bullish sequence, not reversal; RSI 53.52 has massive headroom; 200 SMA is launchpad not ceiling; waiting for resolution means watching institutional money load up
→ vs neutral: Fed cut probability is irrelevant noise; SPCX is story stock with secular AI demand and government contract base, doesn't need rate cuts
| vwma | 139.74 | bullish |
Support: 140.09 · 138.46 · 136.18 · 124.99 | Resistance: 141.43 · 143.69 · 151.94
Technical posture is constructive but unconfirmed: short-term (10 EMA) and medium-term (50 SMA) trends are bullish, MACD shows a confirmed bullish zero-line crossover with positive histogram, and VWMA confirms volume-supported recovery. However, 200 SMA at 141.43 remains overhead resistance and RSI neutral at 53.52 indicates no momentum thrust yet. Recommended action is to wait for a decisive close >141.43 on volume >80M to enter long; aggressive traders may enter now with stop at 133.20 (1× ATR), with 125.77 (2× ATR) as deep stop near Bollinger lower band. A close below 136.18 would invalidate the bullish thesis.
Market Cap
$1.85 T
Forward P/E
87.7x
Price / Book
14.6x
EPS (TTM)
-$1.10
Forward EPS
+$1.60
Book Value
$9.66
Tangible Book Value
-$12.4 B
52-Week High
$225.64
52-Week Low
$104.83
50-Day MA
$136.49
200-Day MA
$141.44
Revenue 2023
$10.39 B
Revenue 2024
$14.02 B
Revenue 2025
$18.67 B
Gross Profit 2023
$4.28 B
Gross Profit 2024
$6.02 B
Gross Profit 2025
$9.22 B
Gross Margin 2025
49.4%
Operating Income 2023
$507 M
Operating Income 2024
$742 M
Operating Income 2025
-$2.06 B
EBITDA 2023
-$663 M
EBITDA 2024
$5.65 B
EBITDA 2025
$4.43 B
Net Income 2023
-$4.63 B
Net Income 2024
$791 M
Net Income 2025
-$4.94 B
R&D Expense 2023
$2.11 B
R&D Expense 2024
$3.46 B
R&D Expense 2025
$8.64 B
SG&A 2023
$1.67 B
SG&A 2024
$1.81 B
SG&A 2025
$2.64 B
Effective Tax Rate
21%
Interest Expense 2025
$1.95 B
Net Interest Income
-$1.45 B
Total Assets 2024
$57.06 B
Total Assets 2025
$92.08 B
Cash & Equivalents 2024
$11.39 B
Cash & Equivalents 2025
$24.75 B
Total Debt 2024
$14.18 B
Total Debt 2025
$23.32 B
Stockholders' Equity 2024
$25.80 B
Stockholders' Equity 2025
$41.33 B
Preferred Equity 2024
$20.94 B
Preferred Equity 2025
$38.75 B
Common Equity 2024
$4.86 B
Common Equity 2025
$2.57 B
Retained Earnings 2024
-$32.10 B
Retained Earnings 2025
-$37.04 B
Working Capital 2024
$4.32 B
Working Capital 2025
$9.55 B
Current Ratio
5.12
Debt-to-Equity
31.21
Long-term Debt Issued 2025
$16.06 B
Net PP&E 2025
$43.86 B
Goodwill & Intangibles 2025
$14.98 B
Gross PP&E
$56.6 B
Operating Cash Flow 2023
$4.52 B
Operating Cash Flow 2024
$5.78 B
Operating Cash Flow 2025
$6.79 B
Capital Expenditure 2023
-$4.42 B
Capital Expenditure 2024
-$11.16 B
Capital Expenditure 2025
-$20.71 B
Free Cash Flow 2023
$0.11 B
Free Cash Flow 2024
-$5.39 B
Free Cash Flow 2025
-$14.12 B
Net Debt Issuance
+$8.90 B
Net Stock Issuance 2023
$0.60 B
Net Stock Issuance 2024
$12.08 B
Net Stock Issuance 2025
$17.68 B
Common Stock Issued 2025
$18.8 B
End Cash Position 2025
$25.12 B
Stock-based Compensation 2023
$679 M
Stock-based Compensation 2025
$1.95 B
Preferred Stock Buybacks 2025
-$1.13 B
Operating Margin (TTM)
-1.80%
Profit Margin (TTM)
-35.66%
Strengths
Concerns
SPCX is a recently IPO'd mega-cap aerospace and defense company with a ~$1.85T market cap, currently in an aggressive investment phase that has pushed it to TTM losses despite strong operational cash flow of $6.79B. Revenue growth of 33.2% in 2025 drove gross margins to 49.4%, but R&D spending exploded to $8.64B (up 150% YoY) as the company funds Starship, Starlink, and AI/space initiatives, resulting in negative free cash flow of -$14.12B. The balance sheet remains strong with $24.75B in cash and a 5.12 current ratio, though tangible book value is deeply negative at -$12.4B and the company relies on continuous capital raises through both debt ($16.06B issued) and equity ($18.8B issued) to fund operations. Analysts project an earnings inflection with forward EPS of +$1.60, but the stock trades below key technical levels and carries premium valuation multiples (87.7x forward P/E, 14.6x P/B) that leave little room for execution setbacks.
Macro: Risk-on macro environment with no recession (8% probability, -1pp week-over-week) and no Fed cuts priced in near term (1% by Sept 2026, 10% by Dec 2026). Policy is restrictive but stable; long-duration growth assets must earn valuations on fundamentals. AI capex secular super-cycle projected at $31 trillion by 2050 (PwC) and $20–30 trillion annually (Musk). SpaceX IPO market cap dominance eroding vs. Anthropic (39% vs. 60% on Polymarket). Treasury yields easing with gold bid; Wall Street reclaiming gains — consistent with soft-landing/late-cycle regime supporting growth/quality over speculative excess.